返回 Agenda
Session Chair(s)
Akira Kawahara, PHD, MPHARM, RPH
(JPMA), Japan
Nobumasa Nakashima
Professor
Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan
Speaker(s)
Future Activity of ICH from MHLW/PMDA’s Point of View
Naoyuki Yasuda, MSC
Pharmaceuticals and Medical Devices Agency, Japan
Future Activity of ICH From the FDA Point of View
Theresa Mullin, PHD
FDA, United States
Associate Center Director - CDER
Future Activity of ICH from the EU Point of View
Emer Cooke, MBA, MSC
European Medicines Agency, Netherlands
Chair, ICMRA; Executive Director
The Future of ICH – Industry Perspective
Peter Honig, MD, MPH, FACP
Advisor and Board Member, United States